APTOF
Price
$3.00
Change
+$0.40 (+15.38%)
Updated
Apr 4 closing price
Capitalization
8.62M
BDTX
Price
$1.35
Change
-$0.04 (-2.86%)
Updated
Apr 7, 04:59 PM (EDT)
Capitalization
79.33M
30 days until earnings call
Ad is loading...

APTOF vs BDTX

Header iconAPTOF vs BDTX Comparison
Open Charts APTOF vs BDTXBanner chart's image
Aptose Biosciences
Price$3.00
Change+$0.40 (+15.38%)
Volume$22.82K
Capitalization8.62M
Black Diamond Therapeutics
Price$1.35
Change-$0.04 (-2.86%)
Volume$27.8K
Capitalization79.33M
APTOF vs BDTX Comparison Chart
Loading...
APTOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BDTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
APTOF vs. BDTX commentary
Apr 08, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APTOF is a StrongBuy and BDTX is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 08, 2025
Stock price -- (APTOF: $3.00 vs. BDTX: $1.40)
Brand notoriety: APTOF and BDTX are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APTOF: 0% vs. BDTX: 49%
Market capitalization -- APTOF: $8.62M vs. BDTX: $79.33M
APTOF [@Biotechnology] is valued at $8.62M. BDTX’s [@Biotechnology] market capitalization is $79.33M. The market cap for tickers in the [@Biotechnology] industry ranges from $283.79B to $0. The average market capitalization across the [@Biotechnology] industry is $2.07B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APTOF’s FA Score shows that 0 FA rating(s) are green whileBDTX’s FA Score has 1 green FA rating(s).

  • APTOF’s FA Score: 0 green, 5 red.
  • BDTX’s FA Score: 1 green, 4 red.
According to our system of comparison, both APTOF and BDTX are a bad buy in the long-term.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APTOF’s TA Score shows that 6 TA indicator(s) are bullish while BDTX’s TA Score has 2 bullish TA indicator(s).

  • APTOF’s TA Score: 6 bullish, 3 bearish.
  • BDTX’s TA Score: 2 bullish, 4 bearish.
According to our system of comparison, APTOF is a better buy in the short-term than BDTX.

Price Growth

APTOF (@Biotechnology) experienced а -9.64% price change this week, while BDTX (@Biotechnology) price change was -13.04% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -9.36%. For the same industry, the average monthly price growth was -17.88%, and the average quarterly price growth was -17.48%.

Reported Earning Dates

BDTX is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (-9.36% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
BDTX($79.3M) has a higher market cap than APTOF($8.62M). APTOF YTD gains are higher at: 1231.558 vs. BDTX (-34.579). APTOF has higher annual earnings (EBITDA): -24.82M vs. BDTX (-78.44M). BDTX has more cash in the bank: 98.6M vs. APTOF (3.32M). APTOF has less debt than BDTX: APTOF (10.7M) vs BDTX (22.2M). APTOF (0) and BDTX (0) have equivalent revenues.
APTOFBDTXAPTOF / BDTX
Capitalization8.62M79.3M11%
EBITDA-24.82M-78.44M32%
Gain YTD1231.558-34.579-3,562%
P/E RatioN/AN/A-
Revenue00-
Total Cash3.32M98.6M3%
Total Debt10.7M22.2M48%
FUNDAMENTALS RATINGS
APTOF: Fundamental Ratings
APTOF
OUTLOOK RATING
1..100
12
VALUATION
overvalued / fair valued / undervalued
1..100
90
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
99
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
APTOFBDTX
RSI
ODDS (%)
Bullish Trend 4 days ago
76%
Bullish Trend 4 days ago
82%
Stochastic
ODDS (%)
Bullish Trend 4 days ago
82%
N/A
Momentum
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
86%
MACD
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 4 days ago
90%
Bearish Trend 4 days ago
90%
TrendMonth
ODDS (%)
Bullish Trend 4 days ago
65%
Bearish Trend 4 days ago
89%
Advances
ODDS (%)
Bullish Trend 4 days ago
80%
Bullish Trend 19 days ago
81%
Declines
ODDS (%)
Bearish Trend 7 days ago
90%
Bearish Trend 4 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 4 days ago
72%
N/A
Aroon
ODDS (%)
Bullish Trend 4 days ago
67%
Bearish Trend 4 days ago
86%
View a ticker or compare two or three
Ad is loading...
APTOF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
BDTX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
IVCTF0.04N/A
N/A
INVICTUS ENERGY LTD.
TIIAY3.19-0.28
-8.07%
Telecom Italia S.p.A.
LGFRY11.70-1.13
-8.81%
Longfor Group Holdings Ltd.
LZAGF563.54-80.96
-12.56%
Lonza Group AG
DRCR0.05-0.01
-19.30%
Dear Cashmere Holding Co.

APTOF and

Correlation & Price change

A.I.dvisor tells us that APTOF and BDTX have been poorly correlated (+30% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that APTOF and BDTX's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APTOF
1D Price
Change %
APTOF100%
+15.38%
BDTX - APTOF
30%
Poorly correlated
-7.28%
LOGC - APTOF
28%
Poorly correlated
-6.17%
MDGL - APTOF
28%
Poorly correlated
-3.89%
SLNO - APTOF
28%
Poorly correlated
-6.49%
HUMA - APTOF
27%
Poorly correlated
-6.90%
More

BDTX and

Correlation & Price change

A.I.dvisor indicates that over the last year, BDTX has been loosely correlated with ACIU. These tickers have moved in lockstep 54% of the time. This A.I.-generated data suggests there is some statistical probability that if BDTX jumps, then ACIU could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BDTX
1D Price
Change %
BDTX100%
-7.28%
ACIU - BDTX
54%
Loosely correlated
-6.21%
RLAY - BDTX
43%
Loosely correlated
-12.66%
CCCC - BDTX
42%
Loosely correlated
-4.73%
ABSI - BDTX
41%
Loosely correlated
+2.01%
ABOS - BDTX
41%
Loosely correlated
-1.02%
More